B. Zimmermann, G. Starke, D. Shaw, B. Elger, and I. Koné, “Actionability and scope should determine the extent of counselling for presymptomatic genetic testing”, Swiss Med Wkly, vol. 150, no. 2728, p. w20274, Jun. 2020.